Delivery Order SPE2DB22D2206-SPE2DB25FJF82
Award Date 8/5/25
Potential Completion Date 8/6/25
Potential Value $26K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $4,467.19 to AmerisourceBergen Drug Corp for Paclitaxel Protein-Bound 100mg on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price contract has no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,650.26 on August 6, 2025, for Paclitaxel Protein-Bound 100mg pharmaceutical product. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 7, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $11,596.30 to AmerisourceBergen Drug Corp for the supply of Paclitaxel Protein-Bound 100mg on September 16, 2025, with an ultimate completion date of September 17, 2025. This firm fixed price, non-set-aside contract is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $7,085.18 to AmerisourceBergen Drug Corp for Paclitaxel Protein-Bound 100mg on June 17, 2025, with an ultimate completion date of June 18, 2025. The contract employs firm fixed price terms with no set-aside designation, indicating it was competitively awarded. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction within...
- The Defense Logistics Agency awarded a $11,158.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Paclitaxel Protein-Bound 100mg on August 6, 2025, with completion scheduled for August 7, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that provides comprehensive global pharmaceutical support for military healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $10,443.06 to AmerisourceBergen Drug Corp for Paclitaxel Protein-Bound 100mg on September 25, 2025, with completion scheduled for September 26, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The contract calls for the supply of this specialized oncology medication to support federal...
- This delivery order, awarded on June 17, 2025, represents a $7,553.38 firm fixed price purchase of Paclitaxel Protein-Bound 100mg pharmaceutical product from AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The award was made by the Defense Logistics Agency (DLA), a Department of Defense component responsible for supply chain management across military operations and healthcare systems. The contract is unclassified as a set-aside and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Paclitaxel 300 mg/50 ml vials with a firm fixed price ceiling value of $1,126.20. This delivery order represents a non-set-aside, competitively awarded procurement supporting the federal government's pharmaceutical supply requirements. The award is fulfillment under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a delivery order valued at $4,001.16 to AmerisourceBergen Drug Corp for the supply of Paclitaxel 300 mg/50 mL vials on August 14, 2025, with completion targeted for August 15, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $556 delivery order to Amerisourcebergen Drug Corporation for 4561357887, which is paclitaxel 300 mg/50 ml vials supplied in 50ml quantities. The firm fixed price order is to be performed in Conshohocken, Pennsylvania from June 27 to June 28, 2023. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen will deliver this chemotherapy drug to support the Defense Logistics Agency's mission to provide medical logistics support to...